SGLT2 Inhibitors Reduce Urinary Tract Infection Risk in Heart Failure Patients in a Real World Propensity Matched Study

More on SGLT2 inhibitors

• SGLT2 inhibitors raise genital but not urinary infection risk

  Clinical Pharmacology and Therapeutics · 4 Oct 2026

• ARNI links to lower osteoporosis risk in heart failure

  Internal and Emergency Medicine · 4 Oct 2026

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026

• Early physical therapy links to lower mortality in heart failure

  Journal of Clinical Medicine · 4 Oct 2026